AstraZeneca Financial Market Data
| Last Close 30-Jun-2008 |
$42.53 |
Price/ Sales Ratio |
0.20 |
| 52-Week High |
$56.60 |
Price/ Book Ratio |
0.40 |
| 52-Week Low |
$35.03 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
0.4 |
Price/ Cash Flow Ratio |
0.78 |
| Market Cap (mil.) |
-- |
Return on Assets |
11.6% |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
23.8% |
| Dividend Rate |
1.87 |
Current Ratio |
1.12 |
| Dividend Yield |
187.0% |
Long-Term Debt/Equity |
1.04 |
| # of Institutional Holders |
271 |
% Owned by Institutions |
9.0% |
| Latest Short Interest Ratio |
5.31 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
11.6% |
34.6% |
64.6% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
8.7% |
98.9% |
167.1% |
This data is provided as per license from EDGAR Online
